Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-07

Clinical Trial Update: Reducing Ketamine-Induced Agitation, by Midazolam or Haloperidol Premedication After Adult Procedural Sedation [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether premedication with midazolam or haloperidol reduces ketamine-induced agitation after adult procedural sedation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL (HALOPERIDOL LACTATE)
  • Midazolam (Midazolam)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Ketamine Induced Agitation | Phase 4 | Status: COMPLETED